Pharmaceutical industry M&A activity grew by 17 per cent in H1 as deal values drop 56 per cent
According to the research data analysed and published by ComprarAcciones.com, merger and acquisition (M&A) deal activity in the pharmaceutical sector rose by 17 per cent in H1 2020, disregarding the economic toll of the global pandemic.It saw a total of 41 deals during the period, but the Q2 2020 deal

